Index | Gene Name Primary | Protein Name | Uniprot ID | Gene Name Synonym | Ligand Name | Structure | PDB Code | ligand desolvation | Ligand Structure | Compound Affinity nM |
1 | EHMT1 | Histone-lysine N-methyltransferase EHMT1 | Q9H9B1 | EUHMTASE1 GLP KIAA1876 KMT1D | jdg | GLP Methyltransferase with Inhibitor EML741- P3121 Crystal Form | 6mbp | 79.06 | | no data |
2 | EHMT1 | Histone-lysine N-methyltransferase EHMT1 | Q9H9B1 | EUHMTASE1 GLP KIAA1876 KMT1D | e72 | Human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E72 | 3mo5 | 69.13 | | 136. |
3 | EHMT1 | Histone-lysine N-methyltransferase EHMT1 | Q9H9B1 | EUHMTASE1 GLP KIAA1876 KMT1D | e67 | human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E67 | 3mo2 | 71.63 | | 244. |
4 | EHMT1 | Histone-lysine N-methyltransferase EHMT1 | Q9H9B1 | EUHMTASE1 GLP KIAA1876 KMT1D | 90p | Crystal structure of catalytic domain of GLP with MS0105 | 5v9j | 78.05 | | no data |
5 | EHMT1 | Histone-lysine N-methyltransferase EHMT1 | Q9H9B1 | EUHMTASE1 GLP KIAA1876 KMT1D | 7kz | Crystal structure of catalytic domain of GLP with MS012 | 5ttg | 73.6 | | no data |
6 | EHMT1 | Histone-lysine N-methyltransferase EHMT1 | Q9H9B1 | EUHMTASE1 GLP KIAA1876 KMT1D | q4a | G9a-like protein lysine methyltransferase inhibition by BIX-01294 | 3fpd | 64.06 | | 700. |
7 | EHMT1 | Histone-lysine N-methyltransferase EHMT1 | Q9H9B1 | EUHMTASE1 GLP KIAA1876 KMT1D | e11 | Human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E11 | 3mo0 | 87.39 | | 154. |
8 | EHMT1 | Histone-lysine N-methyltransferase EHMT1 | Q9H9B1 | EUHMTASE1 GLP KIAA1876 KMT1D | 7l6 | Structure of human GLP SET-domain (EHMT1) in complex with inhibitor MS0124 | 5tuz | 76.62 | | 40. |
9 | EHMT1 | Histone-lysine N-methyltransferase EHMT1 | Q9H9B1 | EUHMTASE1 GLP KIAA1876 KMT1D | 9hj | Structure of human GLP SET-domain (EHMT1) in complex with inhibitor 13 | 5vsd | 80.84 | | 57. |
10 | EHMT1 | Histone-lysine N-methyltransferase EHMT1 | Q9H9B1 | EUHMTASE1 GLP KIAA1876 KMT1D | 9hg | Structure of human GLP SET-domain (EHMT1) in complex with inhibitor 17 | 5vsf | 77.22 | | 94. |
11 | EHMT1 | Histone-lysine N-methyltransferase EHMT1 | Q9H9B1 | EUHMTASE1 GLP KIAA1876 KMT1D | jdg | GLP Methyltransferase with Inhibitor EML741-P212121 Crystal Form | 6mbo | 33.79 | | no data |
12 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q96KQ7 | BAT8 C6orf30 G9A KMT1C NG36 | ciq | Crystal structure of histone lysine methyltransferase g9a with an inhibitor | 3rjw | 70.11 | | 27. |
13 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q96KQ7 | BAT8 C6orf30 G9A KMT1C NG36 | 90p | Crystal structure of catalytic domain of G9a with MS0105 | 5v9i | 76.91 | | no data |
14 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q96KQ7 | BAT8 C6orf30 G9A KMT1C NG36 | 7kz | Crystal structure of catalytic domain of G9a with MS012 | 5ttf | 81.04 | | no data |
15 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q96KQ7 | BAT8 C6orf30 G9A KMT1C NG36 | dxq | Discovery of a 2,4-Diamino-7-aminoalkoxy-quinazoline as a Potent Inhibitor of Histone Lysine Methyltransferase, G9a | 3k5k | 76.16 | | 23. |
16 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q96KQ7 | BAT8 C6orf30 G9A KMT1C NG36 | 2od | Human G9a in Complex with Inhibitor A-366 | 4nvq | 91.94 | | 3.3 |
17 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q96KQ7 | BAT8 C6orf30 G9A KMT1C NG36 | 7l6 | Structure of human G9a SET-domain (EHMT2) in complex with inhibitor MS0124 | 5tuy | 77.92 | | 445. |
18 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q96KQ7 | BAT8 C6orf30 G9A KMT1C NG36 | 9hj | Structure of human G9a SET-domain (EHMT2) in complex with inhibitor 13 | 5vsc | 76.94 | | 510. |
19 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q96KQ7 | BAT8 C6orf30 G9A KMT1C NG36 | 9hg | Structure of human G9a SET-domain (EHMT2) in complex with inhibitor 17: N~2~-cyclopentyl-6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)quinazoline-2,4-diamine | 5vse | 77.92 | | 1070. |
20 | KMT5A | N-lysine methyltransferase KMT5A | Q9NQR1 | PRSET7 SET07 SET8 SETD8 | 75p | human SETD8 in complex with MS2177 | 5t5g | 61.53 | | no data |
21 | KMT5B | Histone-lysine N-methyltransferase KMT5B | Q4FZB7 | SUV420H1 | 539 | The novel SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity | 5cpr | 84.3 | | 27.5 |
22 | PRDM9 | Histone-lysine N-methyltransferase PRDM9 | Q9NQV7 | PFM6 | ks7 | Crystal structure of SAM-bound PRDM9 in complex with MRK-740 inhibitor | 6nm4 | 62.51 | | no data |
23 | SETD7 | Histone-lysine N-methyltransferase SETD7 | Q8WTS6 | KIAA1717 KMT7 SET7 SET9 | 0n6 | SET7/9 in complex with inhibitor (R)-(3-(3-cyanophenyl)-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl)-1,2,3,4-tetrahydroisoquinoline-6- sulfonamide and S-adenosylmethionine | 4e47 | 75.21 | | no data |
24 | SMYD2 | N-lysine methyltransferase SMYD2 | Q9NRG4 | KMT3C | ew4 | Crystal structure of human SET and MYND Domain Containing protein 2 with MTF9975 | 6cby | 81.78 | | no data |
25 | SMYD2 | N-lysine methyltransferase SMYD2 | Q9NRG4 | KMT3C | a4m | SET and MYND Domain Containing protein 2 | 5wcg | 80.09 | | no data |
26 | SMYD2 | N-lysine methyltransferase SMYD2 | Q9NRG4 | KMT3C | ew1 | Crystal structure of human SET and MYND Domain Containing protein 2 with MTF1497 | 6cbx | 84.17 | | no data |
27 | SUV92 | Histone-lysine N-methyltransferase SUV39H2 | Q9H5I1 | KMT1B | nm4 | Methyltransferase domain of human suppressor of variegation 3-9 homolog 2 (SUV39H2) in complex with OTS186935 inhibitor | 6p0r | 77.99 | | no data |